We are live on ! Find out more
PRDS

Pardes Biosciences, Inc. Common Stock

Delisted

PRDS was delisted on the 30th of August, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
ACA
1
Arena Capital Advisors
California
$20.4M +$5.29M +532,393 +35%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$16.6M -$19.3K -1,942 -0.1%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$9.95M
FCM
4
Farallon Capital Management
California
$9.95M
JCM
5
JS Capital Management
New York
$9.95M
PHS
6
PFM Health Sciences
California
$9.95M
RCM
7
RA Capital Management
Massachusetts
$9.95M
PIM
8
Platinum Investment Management
Australia
$9.61M +$9.6M +965,950 New
SRCM
9
Sage Rock Capital Management
New York
$6.62M -$1.59M -160,518 -19%
FCMV
10
Foresite Capital Management V
California
$6M
Millennium Management
11
Millennium Management
New York
$5.09M -$106K -10,620 -2%
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$4.48M
Franklin Resources
13
Franklin Resources
California
$3.98M
HMC
14
Harvard Management Company
Massachusetts
$3.98M
SCM
15
Suvretta Capital Management
New York
$3.98M
EC
16
EcoR1 Capital
California
$3.69M +$2.2M +221,014 +147%
C
17
Chescapmanager
Maryland
$3.47M -$1.38M -138,534 -28%
Citadel Advisors
18
Citadel Advisors
Florida
$3.05M -$1.66M -167,544 -35%
DCM
19
DAFNA Capital Management
California
$2.98M -$497 -50 -0%
GCL
20
Glazer Capital LLC
New York
$2.64M -$1.92M -193,622 -42%
SC
21
Sculptor Capital
New York
$2.41M
WP
22
Woodline Partners
California
$2.38M +$309K +31,130 +15%
RSCM
23
Rock Springs Capital Management
Maryland
$2.08M
OPU
24
Omni Partners US
California
$2M +$2M +201,249 New
6CM
25
683 Capital Management
New York
$1.99M